|Articles|June 15, 2004
Phakic IOL preserves endothelial cell count outcome measure
Study shows cell loss equal to natural aging, allowing IOL to be implanted in young patients
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
3
FDA guidance to help accelerate cell and gene therapies
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5

















